Results 141 to 150 of about 53,857 (331)
Life and ScienceObjective: The use of sedative hypnotics or anxiolytics in adults poses a significant public health concern. Understanding the underlying factors contributing to their use is essential for devising effective preventive interventions.
Mishal Fatima, Sumaira Gul
doaj +1 more source
Potential cardiovascular effects of anxiolytics.
, 2011 Besides traditional risk factors of the occurrence of cardiovascular diseases, various psychological and social factors attract ever greater attention, whereby anxiety is the factor that is more and more mentioned among them. Anxiety disorders increase
Olga Šegvić +3 more
core
Integrative Zoology, EarlyView.Social rank in greater long‐tailed hamsters (Tscherskia triton) shapes gut microbiota composition and metabolite profiles. Dominant males exhibit a “high‐vigilance, metabolically activated” phenotype, with elevated aggression and specific gut microbiota enriched in energy‐harvesting taxa and fecal queuine.
Da Zhang, Xiaoming Xu, Zhibin Zhang
wiley +1 more source
Use of opioids, hypnotics and anxiolytics in Iceland in relation to mortality
, 2020 Bakgrunnur: Íslendingar nota meira af ópíóíðum, svefn- og kvíðastillandi lyfjum samanborið við hin Norðurlöndin. Mikilli notkun þessara lyfja geta fylgt margar aukaverkanir og er samhliða notkun lyfjanna sérstaklega varhugaverð vegna samverkunar sem ...
Heiðrún Sjöfn Þorsteinsdóttir 1995-
core
Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia
Acta Psychiatrica Scandinavica, EarlyView.ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark +2 more
wiley +1 more source
Varenicline for cannabis use disorder: A randomized controlled trial
Addiction, EarlyView.Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark +8 more
wiley +1 more source
Indian Journal of DermatologyDermatology as a branch is a panoramic canvas with a spectrum of manifestation, and psychodermatology is one emerging paradigm in its epicentre. Traditionally, it was thought that psychiatrists deal with “internal” nonvisible disease, while dermatology ...
Ankita Choudhary +3 more
doaj +1 more source
Health systems performance and cancer outcomes.
, 2013 Do the characteristics of health systems influence cancer outcomes? Although caveats are required when undertaking international comparisons of both health systems and cancer outcomes, observed differences cannot solely be explained by data problems or ...
Coleman, Michel P +3 more
core +1 more source
Addiction, EarlyView.Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka +6 more
wiley +1 more source
Infection control in the brain and the eye
Acta Ophthalmologica, EarlyView.Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester +2 more
wiley +1 more source